(Q44721604)

English

Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

R Garand

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

K Beldjord

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

H Cavé

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

C Fossat

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

I Arnoux

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

V Asnafi

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Y Bertrand

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

M-L Boulland

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

C Brouzes

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

E Clappier

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

E Delabesse

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

T Fest

12

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

F Garnache-Ottou

13

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

F Huguet

14

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

M-C Jacob

15

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

E Kuhlein

16

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

S Marty-Grès

17

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A Plesa

18

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

N Robillard

19

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

M Roussel

20

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

J Tkaczuk

21

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

H Dombret

22

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

E Macintyre

23

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

N Ifrah

24

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

M C Béné

25

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A Baruchel

26

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

16 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

370-376

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Treating childhood acute lymphoblastic leukemia without cranial irradiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

New markers for minimal residual disease detection in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

21 January 2018

T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.234

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2012.234

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44721604&oldid=2206868506"